Thar Pharmaceuticals, Inc. is a clinical-stage, specialty pharmaceutical company that reinvents known, safe, on-the-market drugs by improving clinical performance, economic benefits and patient convenience. The company focuses on transforming intravenous drugs into oral drugs for existing and new indications. Created using our platform EnhanceTM Technology, T121, the company’s lead product, is a patented, IV-to-oral transformation of an existing anti-cancer drug.
Improving the Patient Experience
Improving the patient experience is an integral part of solving clinical limitations of existing drugs. Not only are there clinical or chemistry limitations of existing drugs such as low solubility or bio availability, but there are also challenges to patients such intravenous-only drugs with long, painful infusion periods over hours in a day. Thar Pharmaceuticals’ new oral versions of drugs can offer patients more convenience, comfort, activity and mobility than intravenous-only drugs. Oral drugs also save time and cost less, which benefits patients, insurance companies and healthcare companies.
Address : 150 Gamma Drive Pittsburgh, PA 15238 USA
+1 412.963.6800 || firstname.lastname@example.org